<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="other" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Anaesth</journal-id><journal-id journal-id-type="pmc-domain-id">1243</journal-id><journal-id journal-id-type="pmc-domain">ijanaesth</journal-id><journal-id journal-id-type="publisher-id">IJA</journal-id><journal-id journal-id-type="publisher-id">Indian J Anaesth</journal-id><journal-title-group><journal-title>Indian Journal of Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">0019-5049</issn><issn pub-type="epub">0976-2817</issn><publisher><publisher-name>Wolters Kluwer -- Medknow Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12244458</article-id><article-id pub-id-type="pmcid-ver">PMC12244458.1</article-id><article-id pub-id-type="pmcaid">12244458</article-id><article-id pub-id-type="pmcaiid">12244458</article-id><article-id pub-id-type="pmid">40657138</article-id><article-id pub-id-type="doi">10.4103/ija.ija_1216_24</article-id><article-id pub-id-type="publisher-id">IJA-69-664</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review and Meta-Analysis</subject></subj-group></article-categories><title-group><article-title>Effect of perioperative transdermal nicotine patch on postoperative pain: A systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0394-1853</contrib-id><name name-style="western"><surname>Yalla</surname><given-names initials="B">Bharat</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9243-9963</contrib-id><name name-style="western"><surname>Khanna</surname><given-names initials="P">Puneet</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0497-9909</contrib-id><name name-style="western"><surname>Sarkar</surname><given-names initials="S">Soumya</given-names></name><xref rid="aff2" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4265-4398</contrib-id><name name-style="western"><surname>Lal</surname><given-names initials="D">Deepika</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-9256-4179</contrib-id><name name-style="western"><surname>Maheshwari</surname><given-names initials="A">Ankita</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8778-9803</contrib-id><name name-style="western"><surname>Gupta</surname><given-names initials="M">Manish</given-names></name><xref rid="aff3" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3169-6437</contrib-id><name name-style="western"><surname>Garg</surname><given-names initials="B">Bhavuk</given-names></name><xref rid="aff3" ref-type="aff">2</xref></contrib></contrib-group><aff id="aff1">Department of Anaesthesiology, Pain Medicine, and Critical Care, AIIMS, New Delhi, India</aff><aff id="aff2"><label>1</label>Department of Anaesthesiology, AIIMS, Kalyani, West Bengal, India</aff><aff id="aff3"><label>2</label>Department of Orthopaedics, AIIMS, New Delhi, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Puneet Khanna, Department of Anaesthesia, Pain Medicine, and Critical Care, AIIMS, New Delhi - 110 029, New Delhi, India. E-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="K.punit@yahoo.com">K.punit@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>12</day><month>6</month><year>2025</year></pub-date><volume>69</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">492677</issue-id><fpage>664</fpage><lpage>674</lpage><history><date date-type="received"><day>21</day><month>11</month><year>2024</year></date><date date-type="rev-recd"><day>14</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>18</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>11</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-14 15:25:24.943"><day>14</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright: &#169; 2025 Indian Journal of Anaesthesia</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="IJA-69-664.pdf"/><abstract><sec id="st1"><title>Background and Aims:</title><p>Nicotine replacement therapy (NRT) has emerged as a potential intervention for managing perioperative pain. However, their effectiveness remains unclear, as previous studies neither considered the effect of the route of administration nor differentiated the effect between smokers and non-smokers. This systematic review and meta-analysis aimed to determine the effect of a perioperative transdermal nicotine patch on postoperative pain in both smokers and non-smokers compared with a placebo.</p></sec><sec id="st2"><title>Methods:</title><p>We performed a meta-analysis of randomised controlled trials (RCTs) comparing the effects of transdermal nicotine and placebo on postoperative pain. Databases of MEDLINE, EMBASE, CENTRAL, CINAHL, Google Scholar, Web of Science, and the Cochrane Central Register of Controlled Trials were searched. This systematic review and meta-analysis followed the PRISMA guidelines. The findings were evaluated using forest plots and expressed as relative risk (RR) or mean difference (MD) for primary and secondary outcomes.</p></sec><sec id="st3"><title>Results:</title><p>Twelve studies included in the analysis showed no significant difference in pain scores (NRS) at 24 h between the two groups, with an MD &#8722;0.24 [95% confidence interval (CI): &#8722;0.55, 0.07; P = 0.13] (I<sup>2</sup> = 77%, <italic toggle="yes">P</italic> &lt; 0.00001), and there was no significant difference in postoperative opioid consumption (morphine equivalent) MD &#8722;0.92 (95% CI: &#8722;5.04, 3.21; <italic toggle="yes">P</italic> = 0.66) (I<sup>2</sup> = 23%, <italic toggle="yes">P</italic> = 0.27). Similarly, the two groups had no significant differences in the time to first rescue analgesia, postoperative nausea and vomiting (PONV), or patient satisfaction. However, the required information size was not achieved for the outcomes of postoperative opioid requirement, reduction in postoperative pain, PONV, and the time for rescue analgesia.</p></sec><sec id="st4"><title>Conclusion:</title><p>The perioperative transdermal nicotine patch did not significantly reduce postoperative pain scores compared with placebo. There appears to be a significant reduction in smokers, but the evidence is inadequate to conclude this finding.</p></sec></abstract><kwd-group><kwd>Anaesthesia</kwd><kwd>analgesia</kwd><kwd>meta-analysis</kwd><kwd>nicotine replacement therapy</kwd><kwd>opioid</kwd><kwd>postoperative nausea and vomiting</kwd><kwd>postoperative pain</kwd><kwd>smokers</kwd><kwd>transdermal nicotine</kwd></kwd-group><funding-group><funding-statement>Nil.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Effective management of postoperative pain is a crucial element of enhanced recovery protocols and is closely linked to improved surgical outcomes, reduced morbidity, and decreased duration of hospital stays.[<xref rid="R1" ref-type="bibr">1</xref><xref rid="R2" ref-type="bibr">2</xref>] Although opioids are commonly employed for moderate to severe postoperative pain, concerns about their adverse effects and the potential for long-term dependence have heightened interest in multimodal analgesia strategies aimed at minimising opioid use.[<xref rid="R3" ref-type="bibr">3</xref><xref rid="R4" ref-type="bibr">4</xref>]</p><p>Nicotine replacement therapy (NRT) has emerged as a potential intervention for managing perioperative pain, offering a novel approach to pain relief.[<xref rid="R5" ref-type="bibr">5</xref>] Nicotine acts as a full agonist on nicotinic acetylcholine receptors in both the autonomic and central nervous systems, exhibiting stimulatory properties.[<xref rid="R6" ref-type="bibr">6</xref>]</p><p>The perioperative period offers a crucial opportunity for both smoking cessation and pain management through the use of NRT. A comprehensive understanding of how NRT affects postoperative pain and analgesic requirements could enhance perioperative care for both smokers and non-smokers. The analgesic response to nicotine may vary between these groups. Chronic nicotine exposure in smokers can lead to neuroadaptive changes, potentially altering pain perception and response to analgesics.[<xref rid="R7" ref-type="bibr">7</xref>] Evidence indicates that smokers may experience higher baseline pain levels and increased postoperative pain compared to non-smokers.[<xref rid="R8" ref-type="bibr">8</xref>]</p><p>Individual studies have reported conflicting outcomes, with some suggesting analgesic benefits while others indicate no effect or potential harm. A rigorous synthesis of these findings is necessary to clarify the clinical relevance of NRT in surgical patients.</p><p>The efficacy of transdermal nicotine therapy remains uncertain, as previous meta-analyses did not account for the impact of the administration route[<xref rid="R9" ref-type="bibr">9</xref>] nor did they distinguish between the effects on smokers and non-smokers.[<xref rid="R10" ref-type="bibr">10</xref>] This systematic review and meta-analysis seeks to evaluate the impact of a perioperative transdermal nicotine patch on postoperative pain in both smokers and non-smokers, compared to a placebo. The primary objective was to assess the impact of transdermal nicotine compared to a placebo on postoperative pain, measured using the Numerical Rating Scale (NRS), at 24 h postoperatively. Secondary objectives include evaluating postoperative opioid consumption, time to first rescue analgesia, incidence of postoperative nausea and vomiting (PONV), and patient satisfaction.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>This systematic review and meta-analysis followed the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.[<xref rid="R11" ref-type="bibr">11</xref>] The review was registered propsectively with the International Prospective Register of Systematic Reviews PROSPERO (ID: CRD42024497363).</p><sec id="sec2-1"><title>Literature search</title><p>We conducted a comprehensive search of articles in Medline (PubMed), Ovid (Embase), the Cochrane Central Register of Controlled Trials (CENTRAL), and CINAHL. Additionally, we performed manual searches using Google Scholar and ResearchGate. We employed a mix of controlled vocabulary terms and free keywords: &#8216;Transdermal nicotine&#8217; OR &#8216;Nicotine replacement therapy&#8217; AND &#8216;postoperative pain&#8217; OR &#8216;Pain&#8217; OR &#8216;Analgesia&#8217; [<xref rid="ija.ija_1216_24-T1" ref-type="table">Supplementary Table 1</xref>]. There were no restrictions on the publication year. The search was conducted up to November 2024. Moreover, we reviewed references from pertinent studies and review articles to find potential additions to our analysis.</p><table-wrap position="float" id="ija.ija_1216_24-T1" orientation="portrait"><label>Supplementary Table 1</label><caption><p>Search Strategy</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">MEDLINE (via PubMed)<break/>(&#8220;Nicotine&#8221;[Mesh] OR &#8220;Nicotine Replacement Therapy&#8221;[Mesh] OR &#8220;Transdermal Patch&#8221;[Mesh] OR &#8220;nicotine replacement therapy&#8221; OR &#8220;NRT&#8221; OR &#8220;transdermal nicotine&#8221; OR &#8220;nicotine patch&#8221;)<break/>AND<break/>(&#8220;Pain&#8221;[Mesh] OR &#8220;Postoperative Pain&#8221;[Mesh] OR &#8220;Analgesia&#8221;[Mesh] OR &#8220;postoperative pain&#8221; OR &#8220;pain&#8221; OR &#8220;analgesia&#8221;)<break/>(((((&#8220;nicotine replacement therapy&#8221;[All Fields]) OR (transdermal nicotine)) AND (and)) AND (postoperative pain)) OR (postoperative analgesia))<break/>&#8220;Transdermal nicotine&#8221;[MeSH] OR &#8220;Transdermal nicotine&#8221;<break/>&#8220;Nicotine replacement therapy&#8221;[MeSH] OR &#8220;Nicotine replacement therapy&#8221;<break/>&#8220;Postoperative pain&#8221;[MeSH] OR &#8220;Postoperative pain&#8221;<break/>&#8220;Analgesia&#8221;[MeSH] OR &#8220;Analgesia&#8221;<break/>&#8220;Pain&#8221;[MeSH] OR &#8220;Pain&#8221;<break/>(&#8220;Nicotine replacement therapy&#8221; OR &#8220;NRT&#8221; OR &#8220;Transdermal nicotine&#8221;)<break/>(&#8220;Postoperative pain&#8221; OR &#8220;Analgesia&#8221; OR &#8220;Pain&#8221;)<break/>EMBASE (via Ovid)<break/>(&#8216;nicotine replacement therapy&#8217;/exp OR &#8216;nicotine patch&#8217;/exp OR &#8216;transdermal nicotine&#8217; OR &#8216;NRT&#8217;)<break/>AND<break/>(&#8216;postoperative pain&#8217;/exp OR &#8216;pain&#8217;/exp OR &#8216;analgesia&#8217;/exp OR &#8216;postoperative pain&#8217; OR &#8216;pain&#8217; OR &#8216;analgesia&#8217;)<break/>Emtree term: &#8220;Nicotine replacement therapy&#8221; OR &#8220;NRT&#8221; OR &#8220;Transdermal nicotine&#8221;<break/>Emtree term: &#8220;Postoperative pain&#8221; OR &#8220;Analgesia&#8221; OR &#8220;Pain&#8221;<break/>CINAHL (via EBSCOhost)<break/>(MH &#8220;Nicotine Replacement Therapy&#8221; OR MH &#8220;Nicotine&#8221; OR &#8220;nicotine patch&#8221; OR &#8220;transdermal nicotine&#8221; OR &#8220;NRT&#8221;)<break/>AND<break/>(MH &#8220;Postoperative Pain&#8221; OR MH &#8220;Pain&#8221; OR MH &#8220;Analgesia&#8221; OR &#8220;postoperative pain&#8221; OR &#8220;pain&#8221; OR &#8220;analgesia&#8221;)<break/>Google Scholar<break/>&#8220;Nicotine replacement therapy&#8221; OR &#8220;NRT&#8221; OR &#8220;transdermal nicotine&#8221; OR &#8220;nicotine patch&#8221;<break/>AND<break/>&#8220;postoperative pain&#8221; OR &#8220;pain&#8221; OR &#8220;analgesia&#8221;<break/>Web of Science<break/>TS = (&#8220;nicotine replacement therapy&#8221; OR &#8220;nicotine patch&#8221; OR &#8220;transdermal nicotine&#8221; OR &#8220;NRT&#8221;)<break/>AND<break/>TS = (&#8220;postoperative pain&#8221; OR &#8220;pain&#8221; OR &#8220;analgesia&#8221;)<break/>CENTRAL (Cochrane Central Register of Controlled Trials)<break/>(&#8220;nicotine replacement therapy&#8221; OR &#8220;transdermal nicotine&#8221; OR &#8220;nicotine patch&#8221; OR &#8220;NRT&#8221;)<break/>AND<break/>(&#8220;postoperative pain&#8221; OR &#8220;pain&#8221; OR &#8220;analgesia&#8221;)<break/>MeSH descriptor: [Nicotine replacement therapy<break/>MeSH descriptor: [Transdermal nicotine]<break/>MeSH descriptor: [NRT]<break/>MeSH descriptor: [Postoperative pain]<break/>MeSH descriptor: [Analgesia]<break/>MeSH descriptor: [Pain]<break/>(1 OR 2 OR 3) AND (4 OR 5 OR 6)</td></tr></tbody></table></table-wrap><p>We employed the PICO framework to organise our findings. The patient population included adults over 18 years undergoing surgical procedures. The intervention received was transdermal NRT, which was compared to standard postoperative pain management protocols that did not include NRT. The outcomes assessed included the postoperative pain score (NRS) at 24 h, the time to first rescue analgesia, postoperative opioid consumption, the incidence of PONV, and patient satisfaction.</p></sec><sec id="sec2-2"><title>Eligibility criteria</title><p>Randomised controlled trials (RCTs) and controlled cohort studies assessing the impact of transdermal nicotine compared with placebo on postoperative pain in patients undergoing surgery were included. The exclusion criteria included case reports, editorials, expert opinions, and studies in languages other than English. Studies administering nicotine via routes other than the transdermal route were excluded.</p></sec><sec id="sec2-3"><title>Study selection</title><p>Two reviewers, BY and AM, independently examined the titles and abstracts identified through the literature search. Full-text versions of all citations that might meet the eligibility criteria were obtained and assessed for possible inclusion. Any disagreements about inclusion were resolved through discussion with a third reviewer, PK.</p></sec><sec id="sec2-4"><title>Data extraction</title><p>A standardised form for data extraction was created in Microsoft Excel by the reviewer (BY). The extraction process was carried out by BY and MG, with BG verifying the results. This form collected details on smoking status during the publication year, the use of intraoperative analgesics, the dosage and duration of NRT, pain scores, and the incidence of PONV within 24 h. If additional information was needed, the study authors were contacted.</p><p>Two independent reviewers, BY and DL, assessed the bias in the included trials using the Cochrane Collaboration Risk of Bias 2.0 tool.[<xref rid="R12" ref-type="bibr">12</xref>] The risk was classified as low, unclear, or high across several domains, such as deviations from the intervention, missing outcome data, outcome measurement, result selection, and overall bias. A third author, PK, settled any disagreements.</p><p>All seven authors evaluated the quality of evidence using the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) system.[<xref rid="R13" ref-type="bibr">13</xref>] The strength of the evidence was classified as high, moderate, low, or very low quality. Any differences were resolved through consensus.</p></sec><sec id="sec2-5"><title>Primary and secondary outcomes</title><p>The primary outcome was the postoperative pain score, measured using the NRS, at 24 h. The secondary outcomes included postoperative opioid consumption, time to first rescue analgesia, incidence of PONV, and patient satisfaction.</p><p>For dichotomous variables, such as the incidence of PONV, the risk ratio (RR) with a 95% confidence interval (CI) was employed. Continuous variables, including postoperative pain scores, time to first rescue analgesia, postoperative opioid consumption, and patient satisfaction, were expressed as mean differences (MD) with corresponding 95% CI. Significance was set at <italic toggle="yes">P</italic> &lt; 0.05, and the data in the form of median and interquartile range were converted into estimated mean and standard deviation (SD) using the methods of Wan <italic toggle="yes">et al</italic>.[<xref rid="R14" ref-type="bibr">14</xref>] and Luo <italic toggle="yes">et al</italic>.[<xref rid="R15" ref-type="bibr">15</xref>] Heterogeneity was assessed using I&#178; statistics. We used a random-effects model analysis. Subgroup analysis was performed for the outcome of postoperative pain NRS at 24 h, including smokers alone.</p><p>The findings were evaluated using forest plots and expressed as relative risk (RR) or MD for both primary and secondary outcomes. A funnel plot was utilised to assess publication bias in the meta-analysis, and Review Manager 5.4 was employed for the statistical analysis.</p><p>We utilised Trial Sequential Analysis Software 0.9.5.5 Beta (Copenhagen Trial Unit, Copenhagen, Denmark) to perform trial sequential analyses, aiming to assess the impact of perioperative transdermal nicotine patches on postoperative pain. To minimise the probability of type-1 errors, the Z-value thresholds were adjusted using the O&#8217;Brien&#8211;Fleming pending function, which reinstated the intended maximum risk. The crossing of the Z-curve over the O&#8217;Brien&#8211;Fleming &#945;-spending boundaries signified statistical significance. To address the risk of type-2 errors, the &#946;-spending function and futility boundaries were applied. When interventions did not show a difference beyond the anticipated effect, they crossed the futility boundaries. The calculation of information size considered low-bias studies, incorporating a 5% type-1 error risk and 95% power.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>This review included 12 RCTs[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R19" ref-type="bibr">19</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R22" ref-type="bibr">22</xref><xref rid="R23" ref-type="bibr">23</xref><xref rid="R24" ref-type="bibr">24</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref><xref rid="R27" ref-type="bibr">27</xref>] of 312 screened publications [<xref rid="ija.ija_1216_24-F1" ref-type="fig">Figure 1</xref>, <xref rid="ija.ija_1216_24-T2" ref-type="table">Table 1</xref>]. Among these, seven trials[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R23" ref-type="bibr">23</xref><xref rid="R27" ref-type="bibr">27</xref>] raised some concerns regarding the risk of bias [<xref rid="ija.ija_1216_24-F2" ref-type="fig">Figure 2</xref>].</p><fig position="float" id="ija.ija_1216_24-F1" orientation="portrait"><label>Figure 1</label><caption><p>Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJA-69-664-g001.jpg"/></fig><fig position="float" id="ija.ija_1216_24-F2" orientation="portrait"><label>Figure 2</label><caption><p>Risk of bias of the included studies (randomised controlled studies)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJA-69-664-g002.jpg"/></fig><table-wrap position="float" id="ija.ija_1216_24-T2" orientation="portrait"><label>Table 1</label><caption><p>Characteristics of the included studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">First author, year</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Type of surgery</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Design</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Sample size</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Gender</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Dose of NRT/24 h</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Smoking status</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Timing of insertion</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Site of insertion</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Intraoperative analgesia</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Postoperative analgesia</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Anaesthesia</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Zhu <italic toggle="yes">et al</italic>. 2023[<xref rid="R19" ref-type="bibr">19</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Abdominal surgery</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">101</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Males only</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#8804;20 cigars/day=21 mg &gt;20 cigars/day=42 mg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Smokers</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">On the day of admission</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Away from the surgical site</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Sufentanil at induction and remifentanil for maintenance</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Sufentanil infusion</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA with TIVA</td></tr><tr><td align="left" rowspan="1" colspan="1">Seyedsadeghi <italic toggle="yes">et al</italic>. 2023[<xref rid="R26" ref-type="bibr">26</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Laparoscopic cholecystectomy</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Both</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">17.5 mg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-smokers</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1 h before surgery</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Right arm</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Fentanyl infusion</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Meperidine</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA with TIVA</td></tr><tr><td align="left" rowspan="1" colspan="1">Martins Filho <italic toggle="yes">et al</italic>. 2018[<xref rid="R21" ref-type="bibr">21</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Laparoscopic cholecystectomy</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Both</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">14 mg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1 h before induction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Fentanyl bolus</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Morphine bolus</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA with TIVA</td></tr><tr><td align="left" rowspan="1" colspan="1">Olson <italic toggle="yes">et al</italic>. 2009[<xref rid="R25" ref-type="bibr">25</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Abdominal or pelvic surgery</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Both</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">5&#8211;15 mg/16 h</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Smokers only</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1 h before induction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Away from the surgical site</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Fentanyl and morphine bolus</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PCA morphine</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td></tr><tr><td align="left" rowspan="1" colspan="1">Ali and Sakr 2009[<xref rid="R17" ref-type="bibr">17</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Lumber disc surgery</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Both</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">7 mg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-smokers</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2 h before surgery</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Fentanyl infusion</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PCA morphine</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td></tr><tr><td align="left" rowspan="1" colspan="1">Turan <italic toggle="yes">et al</italic>. 2008[<xref rid="R16" ref-type="bibr">16</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Abdominal hysterectomy</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">85</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Males only</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">21 mg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Both</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1 h before induction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Morphine bolus</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PCA morphine</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td></tr><tr><td align="left" rowspan="1" colspan="1">Hong <italic toggle="yes">et al</italic>. 2008[<xref rid="R20" ref-type="bibr">20</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Pelvic and abdominal</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Both</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">5&#8211;15 mg/16 h</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-smokers</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Immediately before induction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Morphine bolus</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PCA morphine</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td></tr><tr><td align="left" rowspan="1" colspan="1">Habib <italic toggle="yes">et al</italic>. 2008[<xref rid="R18" ref-type="bibr">18</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Radical retropubic prostatectomy (RRP)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Males only</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">7 mg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-smokers</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1 h before induction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Behind ear</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Fentanyl infusion</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PCA morphine</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td></tr><tr><td align="left" rowspan="1" colspan="1">FS Landim <italic toggle="yes">et al</italic>. 2020[<xref rid="R22" ref-type="bibr">22</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Molar extraction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Both</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">14 mg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-smokers</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1 h before surgery</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Paracetamol and Diclofenac</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LA with mepivacaine</td></tr><tr><td align="left" rowspan="1" colspan="1">H Nagy and ElKadi 2014[<xref rid="R23" ref-type="bibr">23</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Thoracotomy</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Males only</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">5 mg/16 h</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-smokers</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Immediately before induction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Away from the surgical site</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Fentanyl bolus and TEA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TEA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA with TEA</td></tr><tr><td align="left" rowspan="1" colspan="1">IM Esmat and Kassim 2016[<xref rid="R24" ref-type="bibr">24</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Laparoscopic cholecystectomy</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Females only</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">15 mg/16 h</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-smokers</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2 h before induction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">subclavicular</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Fentanyl bolus</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Meperidine</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td></tr><tr><td align="left" rowspan="1" colspan="1">Malaithong and Munjupong 2017[<xref rid="R27" ref-type="bibr">27</xref>]</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Arthroscopic shoulder surgery</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Both</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">7 mg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Immediately before induction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PCA morphine</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td></tr></tbody></table><table-wrap-foot><fn id="TF-F1"><p>RCT=Randomised Controlled Trial, mg=milligram, h=hour, TEA=Thoracic Epidural Analgesia, PCA=Patient Controlled Analgesia, GA=General Anaesthesia, TIVA=Total Intravenous Anaesthesia</p></fn></table-wrap-foot></table-wrap><p>The surgical procedures undertaken comprised abdominal surgeries,[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R19" ref-type="bibr">19</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R24" ref-type="bibr">24</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref>] thoracotomy,[<xref rid="R22" ref-type="bibr">22</xref>] lumbar disc surgery,[<xref rid="R16" ref-type="bibr">16</xref>] arthroscopic shoulder surgery,[<xref rid="R26" ref-type="bibr">26</xref>] and molar extraction.[<xref rid="R22" ref-type="bibr">22</xref>]</p><p>Seven studies included participants of both genders,[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R22" ref-type="bibr">22</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref><xref rid="R27" ref-type="bibr">27</xref>] Four studies included only male participants,[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R19" ref-type="bibr">19</xref><xref rid="R23" ref-type="bibr">23</xref>] and one study included only female participants.[<xref rid="R24" ref-type="bibr">24</xref>]</p><p>Two studies focused exclusively on smokers,[<xref rid="R19" ref-type="bibr">19</xref><xref rid="R25" ref-type="bibr">25</xref>] while seven studies concentrated solely on non-smokers.[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R22" ref-type="bibr">22</xref><xref rid="R23" ref-type="bibr">23</xref><xref rid="R24" ref-type="bibr">24</xref><xref rid="R26" ref-type="bibr">26</xref>] Additionally, one study included both groups.[<xref rid="R16" ref-type="bibr">16</xref>] Two studies (Martins Filho <italic toggle="yes">et al.</italic>[<xref rid="R21" ref-type="bibr">21</xref>] and Malaithong <italic toggle="yes">et al.</italic>[<xref rid="R27" ref-type="bibr">27</xref>]) did not disclose the smoking status of participants.</p><p>The transdermal nicotine dosage administered varied from 7 to 21 mg per 24h period, and a high dose of 21&#8211;42 mg was administered contingent upon the number of cigarettes smoked by Zhu <italic toggle="yes">et al</italic>.[<xref rid="R19" ref-type="bibr">19</xref>]</p><p>The timing of insertion was immediately before anaesthesia induction in three studies[<xref rid="R20" ref-type="bibr">20</xref><xref rid="R23" ref-type="bibr">23</xref><xref rid="R27" ref-type="bibr">27</xref>] 1 h before induction in six studies,[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R22" ref-type="bibr">22</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref>] 2 h before induction in two studies,[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R24" ref-type="bibr">24</xref>] and on the day of admission in one study.[<xref rid="R19" ref-type="bibr">19</xref>]</p><p>Intraoperative analgesia was administered through various methods, including intravenous fentanyl infusion,[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R26" ref-type="bibr">26</xref>] fentanyl bolus,[<xref rid="R21" ref-type="bibr">21</xref><xref rid="R23" ref-type="bibr">23</xref><xref rid="R24" ref-type="bibr">24</xref><xref rid="R25" ref-type="bibr">25</xref>] morphine bolus,[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R25" ref-type="bibr">25</xref>] and remifentanil infusion.[<xref rid="R19" ref-type="bibr">19</xref>] Postoperative analgesia was managed using several approaches, such as patient-controlled analgesia (PCA) with morphine,[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R27" ref-type="bibr">27</xref>] morphine bolus,[<xref rid="R20" ref-type="bibr">20</xref>] sufentanil infusion.[<xref rid="R18" ref-type="bibr">18</xref>] thoracic epidural analgesia (TEA),[<xref rid="R22" ref-type="bibr">22</xref>] and meperidine.[<xref rid="R24" ref-type="bibr">24</xref><xref rid="R26" ref-type="bibr">26</xref>]</p><sec id="sec2-6"><title>Meta-analysis</title><sec id="sec3-1"><title>Postoperative pain score (NRS) at 24 hours</title><p>Ten studies[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R19" ref-type="bibr">19</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R22" ref-type="bibr">22</xref><xref rid="R23" ref-type="bibr">23</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref><xref rid="R27" ref-type="bibr">27</xref>] with 645 patients were included in both groups (NRT group and Placebo group) i.e. intervention and comparator group. They showed no significant difference in pain scores (NRS) at 24 h between the two groups, with an MD 0.25 (95% CI: &#8722;0.56, 0.06; <italic toggle="yes">P</italic> = 0.12) (I<sup>2</sup> = 78%, <italic toggle="yes">P</italic> &lt; 0.00001) [<xref rid="ija.ija_1216_24-F3" ref-type="fig">Figure 3</xref>a].</p><fig position="float" id="ija.ija_1216_24-F3" orientation="portrait"><label>Figure 3</label><caption><p>(a) Postoperative pain scores (NRS) at 24hr. (b) Postoperative opioid consumption (in morphine equivalents). SD=Standard Deviation, CI=Confidence Interval, IV=Inverse Variance</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJA-69-664-g003.jpg"/></fig><p>The required information size needed to achieve a 95% power, based on the reduction in pain score by 1 at 24 h, was 452 [<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="local_file" xlink:href="IJA-69-664_Suppl1.tif" id="d67e1224" content-type="local-data">Supplementary Figure 1</inline-supplementary-material>].</p><p>Subgroup analysis, focusing solely on smokers in two studies,[<xref rid="R19" ref-type="bibr">19</xref><xref rid="R25" ref-type="bibr">25</xref>] revealed a significant reduction in postoperative pain scores (NRS) at 24 h with MD &#8722;0.56 (95% CI: &#8722;0.62, 0.51; <italic toggle="yes">P</italic> &lt; 0.00001), with no heterogeneity between the studies (I<sup>2</sup> = 0%, <italic toggle="yes">P</italic> = 0.54) [<xref rid="ija.ija_1216_24-F3" ref-type="fig">Figure 3</xref>a].</p><p>For smokers, the required information size, estimated for a power of 95% based on a reduction in pain score by 1 at 24 h, was 117 [<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="local_file" xlink:href="IJA-69-664_Suppl2.tif" id="d67e1247" content-type="local-data">Supplementary Figure 2</inline-supplementary-material>].</p><p>In contrast, subgroup analysis of non-smokers across five studies[<xref rid="R18" ref-type="bibr">18</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R22" ref-type="bibr">22</xref><xref rid="R23" ref-type="bibr">23</xref><xref rid="R26" ref-type="bibr">26</xref>] showed no significant difference between the two groups, with MD &#8722;0.25 (95% CI: &#8722;0.74, 0.23; <italic toggle="yes">P</italic> = 0.31) (I<sup>2</sup> = 65%, <italic toggle="yes">P</italic> = 0.31) [<xref rid="ija.ija_1216_24-F3" ref-type="fig">Figure 3</xref>a].</p></sec><sec id="sec3-2"><title>Postoperative opioid consumption</title><p>A total of 287 patients from five studies[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R27" ref-type="bibr">27</xref>] that were compared for postoperative opioid consumption showed no discernible difference in opioid (morphine equivalent) consumption, with a MD &#8722;0.92 (95% CI: &#8722;5.04, 3.21; <italic toggle="yes">P</italic> = 0.66), with low heterogeneity between the studies (I<sup>2</sup> = 23%, <italic toggle="yes">P</italic> = 0.27) [<xref rid="ija.ija_1216_24-F3" ref-type="fig">Figure 3</xref>b].</p><p>The required information size needed to achieve a 95% power, based on the postoperative opioid reduction of 6 mg morphine equivalent was 470 [<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="local_file" xlink:href="IJA-69-664_Suppl3.tif" id="d67e1304" content-type="local-data">Supplementary Figure 3</inline-supplementary-material>].</p></sec><sec id="sec3-3"><title>Time to first rescue analgesia</title><p>Two studies[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R24" ref-type="bibr">24</xref>] assessed for time to first rescue analgesia, with 90 patients in both groups. There was no significant difference between the two groups, with an MD 94.88 minutes (95% CI: &#8722;73.19, 262.94; <italic toggle="yes">P</italic> = 0.27), with significant heterogeneity between the studies (I<sup>2</sup> = 100%, <italic toggle="yes">P</italic> &lt; 0.00001) [<xref rid="ija.ija_1216_24-F4" ref-type="fig">Figure 4</xref>a]. The wide CI indicates insufficient data to draw a definitive conclusion about this particular outcome.</p><fig position="float" id="ija.ija_1216_24-F4" orientation="portrait"><label>Figure 4</label><caption><p>(a) Time to first rescue analgesia in minutes. (b) Incidence of postoperative nausea and vomiting. (c) Patient satisfaction. SD=Standard Deviation, CI=Confidence Interval, IV=Inverse Variance</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJA-69-664-g004.jpg"/></fig><p>The required information size needed to achieve a 95% power for the prolongation of rescue analgesia by 90 min was 593 [<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="local_file" xlink:href="IJA-69-664_Suppl4.tif" id="d67e1334" content-type="local-data">Supplementary Figure 4</inline-supplementary-material>].</p></sec><sec id="sec3-4"><title>Incidence of postoperative nausea and vomiting</title><p>Nine studies[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R19" ref-type="bibr">19</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R24" ref-type="bibr">24</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref>] presented data on the incidence of PONV, including 551 patients in both groups. The pooled data showed no significant difference in the incidence of PONV between the two groups (RR: 1.09; 95% CI: 0.75, 1.61; <italic toggle="yes">P</italic> = 0.65), with considerable heterogeneity between the studies (I<sup>2</sup>
<italic toggle="yes">=</italic> 70%, <italic toggle="yes">P</italic> = 0.0009<italic toggle="yes">)</italic> [<xref rid="ija.ija_1216_24-F4" ref-type="fig">Figure 4</xref>b].</p><p>The required information size needed to achieve a 95% power, based on a 20% reduction of PONV, was 2894 for the overall population [<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="local_file" xlink:href="IJA-69-664_Suppl5.tif" id="d67e1380" content-type="local-data">Supplementary Figure 5</inline-supplementary-material>].</p></sec></sec><sec id="sec2-7"><title>Patient satisfaction</title><p>Data on patient satisfaction were provided in two trials.[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R17" ref-type="bibr">17</xref>] With 135 patients, they revealed no significant difference between the groups, with a pooled MD 7.37 (95% CI: &#8722;5.36, 20.11; <italic toggle="yes">P</italic> = 0.26) and considerable heterogeneity between the studies (I<sup>2</sup> = 96%, <italic toggle="yes">P</italic> &lt; 0.00001) [<xref rid="ija.ija_1216_24-F4" ref-type="fig">Figure 4</xref>c].</p></sec><sec id="sec2-8"><title>Quality of evidence</title><p>The quality of evidence on the effect of NRT on postoperative pain was very low [<xref rid="ija.ija_1216_24-T3" ref-type="table">Table 2</xref>].</p><table-wrap position="float" id="ija.ija_1216_24-T3" orientation="portrait"><label>Table 2</label><caption><p>Grading of Recommendations, Assessment, Development and Evaluation (GRADE)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="11" rowspan="1">Nicotine replacement therapy compared to placebo for postoperative analgesia</th></tr></thead><tbody><tr><td align="left" colspan="11" rowspan="1">Patient or population: Patients<break/>Setting: Perioperative<break/>Intervention: Nicotine replacement therapy<break/>Comparison: Placebo</td></tr><tr><td align="center" colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="2" colspan="1">
<bold>Outcomes</bold>
</td><td align="center" rowspan="2" colspan="1"/><td align="center" colspan="3" rowspan="1">
<bold>Anticipated absolute effects* (95% CI)</bold>
<hr/>
</td><td align="center" rowspan="2" colspan="1"/><td align="center" rowspan="2" colspan="1">
<bold>Relative effect (95% CI)</bold>
</td><td align="center" rowspan="2" colspan="1"/><td align="center" rowspan="2" colspan="1">
<bold>Number of participants (studies)</bold>
</td><td align="center" rowspan="2" colspan="1"/><td align="center" rowspan="2" colspan="1">
<bold>Certainty of the evidence (GRADE)</bold>
</td></tr><tr><td align="center" rowspan="1" colspan="1">
<bold>Risk with placebo</bold>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<bold>Risk with nicotine replacement therapy</bold>
</td></tr><tr><td align="center" colspan="11" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">PONV</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">396 per 1,000</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">432 per 1,000 (297 to 638)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">RR 1.09 (0.75 to 1.61)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">551 (9 RCTs)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#10753;&#10753;&#10753;&#9711;<break/>Moderate<sup>a,b</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">NRS in both smokers and non-smokers at 24 h</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">MD 0.25 lower (0.56 lower to 0.06 higher)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">645 (10 RCTs)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#10753;&#9711;&#9711;&#9711;<break/>Very low<sup>c,d,e</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative opioid consumption</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">MD 0.92 lower (5.04 lower to 3.21 higher)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">287 (5 RCTs)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#10753;&#10753;&#10753;&#9711;<break/>Moderate<sup>f</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Time to rescue analgesia</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">MD 94.88 higher (73.19 lower to 262.94 higher)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">90 (2 RCTs)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#10753;&#9711;&#9711;&#9711;<break/>Very low<sup>e,g,h</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Patient satisfaction</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">MD 7.37 higher (5.36 lower to 20.11 higher)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">135 (2 RCTs)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#10753;&#9711;&#9711;&#9711;<break/>Very low<sup>e,g,i</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">NRS in smokers at 24 h</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">MD 0.56 lower (0.62 lower to 0.51 lower)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">129 (2 RCTs)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#8853;&#8853;&#8854;&#8854;<break/>Low<sup>e,g,i</sup></td></tr><tr><td align="left" colspan="11" rowspan="1">*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<break/>CI=confidence interval; MD=mean difference; RR=risk ratio; SMD=standardised mean difference</td></tr><tr><td align="left" colspan="11" rowspan="1">High certainty: We are very confident that the true effect lies close to that of the estimate of the effect.<break/>Moderate certainty: We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<break/>Low certainty: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<break/>Very low certainty: We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.</td></tr></tbody></table><table-wrap-foot><fn id="TF-F2"><p><sup>a</sup>Three studies have some concerns of risk of bias. <sup>b</sup>Heterogeneity is 70%. <sup>c</sup>Four studies have unclear risk of bias. <sup>d</sup>Heterogeneity is 76%. <sup>e</sup>Funnel plot of this outcome seems to have an apparent publication bias. <sup>f</sup>Two studies have unclear risk of bias. <sup>g</sup>one study has unclear risk of bias. <sup>h</sup>Heterogeneity is 97%. <sup>i</sup>Heterogeneity is 96%</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-9"><title>Trial sequential analysis</title><p>The required information size needed to achieve a 95% power, based on the reduction in pain score by 1 at 24 h, postoperative opioid reduction of 6 mg morphine equivalent, and 20% reduction of PONV were 452, 470, and 2894 for the overall population, and the sample size in the current analysis were 645, 287, and 551, respectively.</p><p>Among smokers, the required information size was estimated for a power of 95% based on the reduction in pain score by 1 at 24 h, and the prolongation of rescue analgesia by 90 min. The required information sizes were 117 and 593, and the sample sizes in the current analysis were 129 and 90, respectively.</p><p>Thus, further studies are required to generate conclusive evidence on the impact on postoperative opioid requirement, PONV, and the time to rescue analgesia, as the necessary information size has not been achieved [Supplementary Figures <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="local_file" xlink:href="IJA-69-664_Suppl1.tif" id="d67e1641" content-type="local-data">1</inline-supplementary-material>&#8211;<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="local_file" xlink:href="IJA-69-664_Suppl5.tif" id="d67e1644" content-type="local-data">5</inline-supplementary-material>].</p></sec><sec id="sec2-10"><title>Publication bias</title><p>To assess publication bias for the primary outcome of postoperative pain at 24 h, a funnel plot was used [<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="local_file" xlink:href="IJA-69-664_Suppl6.tif" id="d67e1651" content-type="local-data">Supplementary Figure 6</inline-supplementary-material>].</p></sec></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>This meta-analysis demonstrated that the administration of therapeutic nicotine through the transdermal route is associated with no significant reduction in postoperative pain scores at 24 h post-surgery, without any significant difference in postoperative opioid consumption, time to first rescue analgesia, incidence of PONV, and patient satisfaction compared with placebo.</p><p>The analgesic properties of nicotine were initially demonstrated by Pollock LJ <italic toggle="yes">et al</italic>. in a feline model of visceral pain,[<xref rid="R28" ref-type="bibr">28</xref>] which is believed to be mediated by the nicotinic acetylcholine receptor (nAChR) a pentameric ligand-gated ion channels, formed by a combination of subunits (&#945; 1-10, &#946; 1-4, &#947;, &#948;, &#603;)[<xref rid="R6" ref-type="bibr">6</xref><xref rid="R29" ref-type="bibr">29</xref>] and primarily through the &#945;4&#946;2 subunit.[<xref rid="R30" ref-type="bibr">30</xref><xref rid="R31" ref-type="bibr">31</xref>] Activation of this receptor subunit stimulates the release of spinal norepinephrine, and the administration of the nAChR antagonist mecamylamine was found to attenuate the analgesic effects of nicotine in mice,[<xref rid="R32" ref-type="bibr">32</xref><xref rid="R33" ref-type="bibr">33</xref>] while other mechanisms involving antagonism at the &#945;9/10 subunit[<xref rid="R34" ref-type="bibr">34</xref>] and action on the &#956; receptor[<xref rid="R35" ref-type="bibr">35</xref>] and &#945;7 prolong the analgesic effect of nicotine.[<xref rid="R30" ref-type="bibr">30</xref><xref rid="R35" ref-type="bibr">35</xref>] Additionally, mediated through its anti-inflammatory properties[<xref rid="R36" ref-type="bibr">36</xref><xref rid="R37" ref-type="bibr">37</xref>] and endogenous opioid peptides, it produces analgesic effects.[<xref rid="R38" ref-type="bibr">38</xref>]</p><p>A previous meta-analysis[<xref rid="R9" ref-type="bibr">9</xref>] that showed no statistically significant benefit in perioperative analgesia did not consider the effect of the route of administration; it included both intranasal and transdermal routes, where the peak serum nicotine concentrations differ. In contrast, the current analysis included only transdermal nicotine alone where the peak plasma concentration was achieved between 150 and 210 min after the application of the patch,[<xref rid="R39" ref-type="bibr">39</xref><xref rid="R40" ref-type="bibr">40</xref>] and the active principle was absorbed gradually over 24 hours, resulting in less variability in plasma nicotine levels[<xref rid="R41" ref-type="bibr">41</xref><xref rid="R42" ref-type="bibr">42</xref>] and a stable serum concentration with acceptable inter-patient variability;[<xref rid="R43" ref-type="bibr">43</xref>] in addition, the cumulative analgesic effect seems to persist for up to 80 h.[<xref rid="R23" ref-type="bibr">23</xref>]</p><p>There exist disparities between genders, as male individuals exhibit an elevated pain tolerance upon application of transdermal nicotine patches, whereas such an effect is not observed in females.[<xref rid="R44" ref-type="bibr">44</xref><xref rid="R45" ref-type="bibr">45</xref><xref rid="R46" ref-type="bibr">46</xref>] Three studies in our analysis which were done on males alone showed a benefit of NRT in all. These differences in pain thresholds between both genders can be due to pain response modulation by oestrogen.[<xref rid="R47" ref-type="bibr">47</xref>]</p><p>In smokers, abstinence during the perioperative period demonstrated a significant increase in pain sensitivity compared to non-deprived or non-smokers, due to the upregulation of &#945;4&#946;2 receptors and a sudden increase in unbound nAChR.[<xref rid="R48" ref-type="bibr">48</xref><xref rid="R49" ref-type="bibr">49</xref>] In our analysis, two studies[<xref rid="R19" ref-type="bibr">19</xref><xref rid="R25" ref-type="bibr">25</xref>] included smokers alone, and one study[<xref rid="R25" ref-type="bibr">25</xref>] indicated no notable advantage, but it involved a small sample size and a lower dose of NRT. The other study&#8217;s[<xref rid="R19" ref-type="bibr">19</xref>] dosing was based on tobacco use and dependence guidelines,[<xref rid="R50" ref-type="bibr">50</xref>] which propose an initial transdermal nicotine replacement dose of 21 mg daily for individuals who smoke &#8804;20 cigarettes per day and 42 mg for individuals who smoke &gt;20 cigarettes per day; even the 21 mg patch was discovered to only replace about half of the baseline serum nicotine levels in these smokers. Consequently, higher doses of nicotine patches may be necessary for acute abstinent smokers to assess the effectiveness of NRT in addressing nicotine withdrawal-related pain sensitivity changes. Restoring nicotine at a level equivalent to regular smoking exposure in smoking-abstinent patients led to a decrease in postoperative pain and opioid consumption. Thus, smokers need higher perioperative dosing of NRT based on the number of cigarettes smoked to combat the changes in pain sensitivity associated with nicotine withdrawal.</p><p>Even though the subgroup of smokers showed a significant decrease in postoperative pain, opioid consumption in this subgroup was demonstrated by only one study,[<xref rid="R25" ref-type="bibr">25</xref>] which showed no significant difference.</p><p>Few studies[<xref rid="R51" ref-type="bibr">51</xref><xref rid="R52" ref-type="bibr">52</xref><xref rid="R53" ref-type="bibr">53</xref><xref rid="R54" ref-type="bibr">54</xref>] demonstrated that smokers were less likely to suffer from PONV than non-smokers. Consequently, the perioperative use of nicotine as a prophylactic measure for PONV was explored. Ionesu <italic toggle="yes">et al</italic>.[<xref rid="R55" ref-type="bibr">55</xref>] demonstrated a significant reduction in the incidence of PONV in patients receiving NRT. Later, Czanrnetzki <italic toggle="yes">et al</italic>.[<xref rid="R56" ref-type="bibr">56</xref>] showed no significant difference; instead, patients receiving NRT had an earlier incidence of PONV. In our analysis, four studies[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R19" ref-type="bibr">19</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref>] showed benefits, four studies[<xref rid="R16" ref-type="bibr">16</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R24" ref-type="bibr">24</xref>] showed disadvantage, and one study[<xref rid="R21" ref-type="bibr">21</xref>] showed no difference, with an overall pooled result of no significant difference between the two. The mechanism is thought to be mediated through inhibition of receptors mediated in PONV, such as D2, 5HT3, and histamine,[<xref rid="R54" ref-type="bibr">54</xref>] and smoking increases the metabolism of drugs (including anaesthetics responsible for PONV) by increasing CYTP450;[<xref rid="R57" ref-type="bibr">57</xref>] In addition, nicotine also increases GI stimulation (motility).[<xref rid="R54" ref-type="bibr">54</xref>] However, two studies[<xref rid="R19" ref-type="bibr">19</xref><xref rid="R26" ref-type="bibr">26</xref>] among the four[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R19" ref-type="bibr">19</xref><xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref>] that showed benefit used total intravenous anaesthesia, which can be confounding.</p><p>This study has several limitations. The included studies used the NRS tool as a measurement of analgesia, which is subjective instead of morphine equivalent, and included different types of surgery, as nicotine has variable antinociceptive properties in somatic and visceral pain,[<xref rid="R58" ref-type="bibr">58</xref><xref rid="R59" ref-type="bibr">59</xref>] encompassing both sex and using different doses of NRT in different studies. In addition, serum nicotine levels were not measured, and no dose-response relationship was investigated. No standard anaesthesia protocol was followed, as volatile anaesthetic agents were believed to be nicotinic antagonists,[<xref rid="R60" ref-type="bibr">60</xref><xref rid="R61" ref-type="bibr">61</xref><xref rid="R62" ref-type="bibr">62</xref>] and there was significant heterogeneity across the studies. Additionally, the haemodynamic variables were not examined.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>The perioperative transdermal nicotine patch did not demonstrate a significant reduction in postoperative pain scores, time to first rescue analgesia, incidence of postoperative nausea vomiting, or patient satisfaction compared with placebo. It appears that there is a significant reduction in smokers, but the evidence is inadequate to conclude this finding.</p><sec sec-type="data-availability" id="sec2-11"><title>Data availability</title><p>The data for this systematic review and/or meta-analysis may be requested with reasonable justification from the authors (via email to the corresponding author) and will be shared upon request.</p></sec><sec sec-type="COI-statement" id="sec2-12"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec><sec sec-type="supplementary-material"><supplementary-material id="SD1" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 1</label><caption><p>TSA for a reduction in postoperative pain score by 1 at 24 h. TSA=trial sequential analysis</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJA-69-664_Suppl1.tif" id="d67e1861" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SD2" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 2</label><caption><p>TSA for a reduction in postoperative pain score by 1 at 24 h in smokers. TSA=trial sequential analysis</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJA-69-664_Suppl2.tif" id="d67e1866" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SD3" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 3</label><caption><p>TSA for postoperative opioid reduction 6 mg morphine equivalent. TSA=trial sequential analysis</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJA-69-664_Suppl3.tif" id="d67e1871" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SD4" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 4</label><caption><p>TSA for prolongation of rescue analgesia by 90 minutes. TSA=trial sequential analysis</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJA-69-664_Suppl4.tif" id="d67e1876" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SD5" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 5</label><caption><p>TSA for 20% reduction of PONV. TSA=trial sequential analysis, PONV=postoperative nausea and vomiting</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJA-69-664_Suppl5.tif" id="d67e1881" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SD6" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 6</label><caption><p>Funnel plot for the primary outcome postoperative pain scores (NRS) at 24 h. NRS=numerical rating scale</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJA-69-664_Suppl6.tif" id="d67e1886" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Kehlet</surname><given-names>H</given-names></name><name name-style="western"><surname>Dahl</surname><given-names>JB</given-names></name></person-group><article-title>Anaesthesia, surgery, and challenges in postoperative recovery</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>1921</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14667752</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(03)14966-5</pub-id></element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Wick</surname><given-names>EC</given-names></name><name name-style="western"><surname>Grant</surname><given-names>MC</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CL</given-names></name></person-group><article-title>Postoperative multimodal analgesia pain management with nonopioid analgesics and techniques: A review</article-title><source>JAMA Surg</source><year>2017</year><volume>152</volume><fpage>691</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">28564673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2017.0898</pub-id></element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Oderda</surname><given-names>GM</given-names></name><name name-style="western"><surname>Said</surname><given-names>Q</given-names></name><name name-style="western"><surname>Evans</surname><given-names>RS</given-names></name><name name-style="western"><surname>Stoddard</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Lloyd</surname><given-names>J</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>K</given-names></name><etal/></person-group><article-title>Opioid-related adverse drug events in surgical hospitalisations: Impact on costs and length of stay</article-title><source>Ann Pharmacother</source><year>2007</year><volume>41</volume><fpage>400</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17341537</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1345/aph.1H386</pub-id></element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Ladha</surname><given-names>KS</given-names></name><name name-style="western"><surname>Neuman</surname><given-names>MD</given-names></name><name name-style="western"><surname>Broms</surname><given-names>G</given-names></name><name name-style="western"><surname>Bethell</surname><given-names>J</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>BT</given-names></name><name name-style="western"><surname>Wijeysundera</surname></name><etal/></person-group><article-title>Opioid use after surgery: A retrospective cohort study</article-title><source>BMJ</source><year>2019</year><volume>364</volume><fpage>k3210</fpage></element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Benowitz</surname><given-names>NL</given-names></name></person-group><article-title>Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics</article-title><source>Annu Rev Pharmacol Toxicol</source><year>2009</year><volume>49</volume><fpage>57</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">18834313</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.pharmtox.48.113006.094742</pub-id><pub-id pub-id-type="pmcid">PMC2946180</pub-id></element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Damaj</surname><given-names>MI</given-names></name><name name-style="western"><surname>Glassco</surname><given-names>W</given-names></name><name name-style="western"><surname>Aceto</surname><given-names>MD</given-names></name><name name-style="western"><surname>Martin</surname><given-names>BR</given-names></name></person-group><article-title>Antinociceptive effects of nicotine in mice: Involvement of supraspinal mechanisms</article-title><source>J Pharmacol Exp Ther</source><year>1998</year><volume>284</volume><fpage>1058</fpage><lpage>65</lpage></element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Weingarten</surname><given-names>TN</given-names></name><name name-style="western"><surname>Mantilla</surname><given-names>CB</given-names></name><name name-style="western"><surname>Hooten</surname><given-names>WM</given-names></name><name name-style="western"><surname>Warner</surname><given-names>DO</given-names></name></person-group><article-title>Smoking and pain: Pathophysiology and clinical implications</article-title><source>Anesthesiology</source><year>2010</year><volume>113</volume><fpage>977</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">20864835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ALN.0b013e3181ebdaf9</pub-id></element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Wadgave</surname><given-names>U</given-names></name><name name-style="western"><surname>Nagesh</surname><given-names>L</given-names></name></person-group><article-title>Nicotine replacement therapy: An overview</article-title><source>Int J Health Sci (Qassim)</source><year>2016</year><volume>10</volume><fpage>425</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">27610066</pub-id><pub-id pub-id-type="pmcid">PMC5003586</pub-id></element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Mishriky</surname><given-names>BM</given-names></name><name name-style="western"><surname>Habib</surname><given-names>AS</given-names></name></person-group><article-title>Nicotine for postoperative analgesia: A systematic review and meta-analysis</article-title><source>Anesth Analg</source><year>2014</year><volume>119</volume><fpage>268</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">24384863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ANE.0b013e3182a8fa7b</pub-id></element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>da Silva Barbirato</surname><given-names>D</given-names></name><name name-style="western"><surname>de Melo Vasconcelos</surname><given-names>AF</given-names></name><name name-style="western"><surname>Dantas de Moraes</surname><given-names>SL</given-names></name><name name-style="western"><surname>Pellizzer</surname><given-names>EP</given-names></name><name name-style="western"><surname>do Egito Vasconcelos</surname><given-names>BC</given-names></name></person-group><article-title>Analgesic potential of transdermal nicotine patch in surgery: A systematic review and meta-analysis of randomised placebo-controlled trials</article-title><source>Eur J Clin Pharmacol</source><year>2023</year><volume>79</volume><fpage>589</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">36947193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00228-023-03475-7</pub-id></element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>MJ</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>JE</given-names></name><name name-style="western"><surname>Bossuyt</surname><given-names>PM</given-names></name><name name-style="western"><surname>Boutron</surname><given-names>I</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>TC</given-names></name><name name-style="western"><surname>Mulrow</surname><given-names>CD</given-names></name><etal/></person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n71</fpage><comment>doi: 10.1136/bmj.n71</comment><pub-id pub-id-type="pmid">33782057</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id></element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Sterne</surname><given-names>JAC</given-names></name><name name-style="western"><surname>Savovi&#263;</surname><given-names>J</given-names></name><name name-style="western"><surname>Page</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Elbers</surname><given-names>RG</given-names></name><name name-style="western"><surname>Blencowe</surname><given-names>NS</given-names></name><name name-style="western"><surname>Boutron</surname><given-names>I</given-names></name><etal/></person-group><article-title>RoB 2: A revised tool for assessing risk of bias in randomised trials</article-title><source>BMJ</source><year>2019</year><volume>366</volume><fpage>l4898</fpage><comment>doi: 10.1136/bmj.l4898</comment><pub-id pub-id-type="pmid">31462531</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.l4898</pub-id></element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal" publication-format="print"><article-title>GRADE handbook</article-title><comment><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gdt.gradepro.org/app/handbook/handbook.html">https://gdt.gradepro.org/app/handbook/handbook.html</uri>. [Last accessed on 2024 Jan 26]</comment></element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Tong</surname><given-names>T</given-names></name></person-group><article-title>Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range</article-title><source>BMC Med Res Methodol</source><year>2014</year><volume>14</volume><fpage>135</fpage><comment>doi: 10.1186/1471-2288-14-135</comment><pub-id pub-id-type="pmid">25524443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2288-14-135</pub-id><pub-id pub-id-type="pmcid">PMC4383202</pub-id></element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>D</given-names></name><name name-style="western"><surname>Wan</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Tong</surname><given-names>T</given-names></name></person-group><article-title>Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range</article-title><source>Stat Methods Med Res</source><year>2018</year><volume>27</volume><fpage>1785</fpage><lpage>805</lpage><pub-id pub-id-type="pmid">27683581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0962280216669183</pub-id></element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Turan</surname><given-names>A</given-names></name><name name-style="western"><surname>White</surname><given-names>PF</given-names></name><name name-style="western"><surname>Koyuncu</surname><given-names>O</given-names></name><name name-style="western"><surname>Karamanliodlu</surname><given-names>B</given-names></name><name name-style="western"><surname>Kaya</surname><given-names>G</given-names></name><name name-style="western"><surname>Apfel</surname><given-names>CC</given-names></name></person-group><article-title>Transdermal nicotine patch failed to improve postoperative pain management</article-title><source>Anesth Analg</source><year>2008</year><volume>107</volume><fpage>1011</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18713922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ane.0b013e31816ba3bb</pub-id></element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>AR</given-names></name><name name-style="western"><surname>Sakr</surname><given-names>SA</given-names></name></person-group><article-title>Pre-emptive use of transdermal nicotine patch in lumber disc surgery: Its effects on intraoperative anaesthetic and analgesic requirements, haemodynamics and postoperative analgesia</article-title><source>Analgesia Aust J Basic Appl Sci</source><year>2009</year><volume>3</volume><fpage>1096</fpage><lpage>3</lpage></element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Habib</surname><given-names>AS</given-names></name><name name-style="western"><surname>White</surname><given-names>WD</given-names></name><name name-style="western"><surname>El Gasim</surname><given-names>MA</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>G</given-names></name><name name-style="western"><surname>Polascik</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Moul</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Transdermal nicotine for analgesia after radical retropubic prostatectomy</article-title><source>Anesth Analg</source><year>2008</year><volume>107</volume><fpage>999</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">18713920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ane.0b013e31816f2616</pub-id></element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>C</given-names></name><name name-style="western"><surname>Bi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wei</surname><given-names>K</given-names></name><name name-style="western"><surname>Tao</surname><given-names>K</given-names></name><name name-style="western"><surname>Hu</surname><given-names>L</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Z</given-names></name></person-group><article-title>Effect of perioperative high-dose transdermal nicotine patch on pain sensitivity among male abstinent tobacco smokers undergoing abdominal surgery: A randomized controlled pilot study</article-title><source>Addiction</source><year>2023</year><volume>118</volume><fpage>1579</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">37132069</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/add.16224</pub-id></element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>D</given-names></name><name name-style="western"><surname>Conell-Price</surname><given-names>J</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>S</given-names></name><name name-style="western"><surname>Flood</surname><given-names>P</given-names></name></person-group><article-title>Transdermal nicotine patch for postoperative pain management: A pilot dose-ranging study</article-title><source>Anesth Analg</source><year>2008</year><volume>107</volume><fpage>1005</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">18713921</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ane.0b013e318163204f</pub-id></element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Martins Filho</surname><given-names>ED</given-names></name><name name-style="western"><surname>Vasconcelos</surname><given-names>CFDM</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>FDSC</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>ADF</given-names></name><name name-style="western"><surname>Ferraz</surname><given-names>&#193;AB</given-names></name></person-group><article-title>Evaluation of nicotine patch in pain control of patients undergoing laparoscopic cholecystectomy</article-title><source>Rev Col Bras Cirdoi</source><year>2018</year><volume>45</volume><fpage>e1756</fpage><comment>doi: 10.1590/0100-6991e-20181756</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/0100-6991e-20181756</pub-id><pub-id pub-id-type="pmid">29947648</pub-id></element-citation></ref><ref id="R22"><label>22.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Landim</surname><given-names>FS</given-names></name><name name-style="western"><surname>Laureano Filho</surname><given-names>JR</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>J</given-names></name><name name-style="western"><surname>do Egito Vasconcelos</surname><given-names>BC</given-names></name></person-group><article-title>Effectiveness of nicotine patch for the control of pain, oedema, and trismus following third molar surgery: A randomized clinical trial</article-title><source>Int J Oral Maxillofac Surg</source><year>2020</year><volume>49</volume><fpage>1508</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">32381373</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijom.2019.08.013</pub-id></element-citation></ref><ref id="R23"><label>23.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Nagy</surname><given-names>HIA</given-names></name><name name-style="western"><surname>ElKadi</surname><given-names>HW</given-names></name></person-group><article-title>Transdermal nicotine patch as adjunctive analgesic modality to thoracic epidural analgesia for post-thoracotomy pain</article-title><source>Egypt J Cardiothorac Anesth</source><year>2014</year><volume>8</volume><fpage>75</fpage><lpage>82</lpage></element-citation></ref><ref id="R24"><label>24.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Esmat</surname><given-names>IM</given-names></name><name name-style="western"><surname>Kassim</surname><given-names>DY</given-names></name></person-group><article-title>Comparative study between transdermal nicotine and melatonin patches on postoperative pain relief after laparoscopic cholecystectomy, a double-blind, placebo-controlled trial</article-title><source>Egypt J Anaesth</source><year>2016</year><volume>32</volume><fpage>299</fpage><lpage>307</lpage></element-citation></ref><ref id="R25"><label>25.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Olson</surname><given-names>LC</given-names></name><name name-style="western"><surname>Hong</surname><given-names>D</given-names></name><name name-style="western"><surname>Conell-Price</surname><given-names>JS</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>S</given-names></name><name name-style="western"><surname>Flood</surname><given-names>P</given-names></name></person-group><article-title>A transdermal nicotine patch is not effective for postoperative pain management in smokers: A pilot dose-ranging study</article-title><source>Anesth Analg</source><year>2009</year><volume>109</volume><fpage>1987</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">19923530</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ANE.0b013e3181bd1612</pub-id></element-citation></ref><ref id="R26"><label>26.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Seyedsadeghi</surname><given-names>M</given-names></name><name name-style="western"><surname>Arabzadeh</surname><given-names>A</given-names></name><name name-style="western"><surname>Entezariasl</surname><given-names>M</given-names></name><name name-style="western"><surname>Shahbazzadegan</surname><given-names>B</given-names></name><name name-style="western"><surname>Dindar</surname><given-names>S</given-names></name><name name-style="western"><surname>Isazadehfar</surname><given-names>K</given-names></name></person-group><article-title>The effect of nicotine patch on reducing nausea, vomiting, and pain following laparoscopic cholecystectomy: A randomized clinical trial</article-title><source>Addict Health</source><year>2023</year><volume>15</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">37560080</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.34172/ahj.2023.1364</pub-id><pub-id pub-id-type="pmcid">PMC10408744</pub-id></element-citation></ref><ref id="R27"><label>27.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Malaithong</surname><given-names>W</given-names></name><name name-style="western"><surname>Munjupong</surname><given-names>S</given-names></name></person-group><article-title>Efficacy of a transdermal nicotine patch in pain relief after arthroscopic shoulder surgery: A randomized controlled trial</article-title><source>J Med Assoc Thailand</source><year>2017</year><volume>100</volume><fpage>901.</fpage></element-citation></ref><ref id="R28"><label>28.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Pollock</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Davis</surname><given-names>L</given-names></name></person-group><article-title>Visceral and referred pain</article-title><source>Arch Neurol Psychiatry</source><year>1935</year><volume>34</volume><fpage>1041</fpage><lpage>54</lpage></element-citation></ref><ref id="R29"><label>29.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>HN</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>BA</given-names></name><name name-style="western"><surname>Perry</surname><given-names>DC</given-names></name></person-group><article-title>Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography</article-title><source>J Pharmacol Exp Ther</source><year>2003</year><volume>307</volume><fpage>1090</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">14560040</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/jpet.103.056408</pub-id></element-citation></ref><ref id="R30"><label>30.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Damaj</surname><given-names>MI</given-names></name><name name-style="western"><surname>Fonck</surname><given-names>C</given-names></name><name name-style="western"><surname>Marks</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Deshpande</surname><given-names>P</given-names></name><name name-style="western"><surname>Labarca</surname><given-names>C</given-names></name><name name-style="western"><surname>Lester</surname><given-names>HA</given-names></name><etal/></person-group><article-title>Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice</article-title><source>J Pharmacol Exp Ther</source><year>2007</year><volume>321</volume><fpage>1161</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17371806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/jpet.106.112649</pub-id></element-citation></ref><ref id="R31"><label>31.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>B</given-names></name><name name-style="western"><surname>Hierl</surname><given-names>M</given-names></name><name name-style="western"><surname>Clarkin</surname><given-names>K</given-names></name><name name-style="western"><surname>Juan</surname><given-names>T</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>H</given-names></name><name name-style="western"><surname>van der Valk</surname><given-names>M</given-names></name><etal/></person-group><article-title>Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain</article-title><source>Pain</source><year>2010</year><volume>149</volume><fpage>33</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">20167427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pain.2010.01.007</pub-id></element-citation></ref><ref id="R32"><label>32.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Marubio</surname><given-names>LM</given-names></name><name name-style="western"><surname>del Mar Arroyo-Jimenez</surname><given-names>M</given-names></name><name name-style="western"><surname>Cordero-Erausquin</surname><given-names>M</given-names></name><name name-style="western"><surname>L&#233;na</surname><given-names>C</given-names></name><name name-style="western"><surname>Le Nov&#232;re</surname><given-names>N</given-names></name><name name-style="western"><surname>de Kerchove d&#8217;Exaerde</surname><given-names>A</given-names></name><etal/></person-group><article-title>Reduced antinociception in mice lacking neuronal nicotinic receptor subunits</article-title><source>Nature</source><year>1999</year><volume>398</volume><fpage>805</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">10235262</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/19756</pub-id></element-citation></ref><ref id="R33"><label>33.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Caggiula</surname><given-names>AR</given-names></name><name name-style="western"><surname>Epstein</surname><given-names>LH</given-names></name><name name-style="western"><surname>Perkins</surname><given-names>KA</given-names></name><name name-style="western"><surname>Saylor</surname><given-names>S</given-names></name></person-group><article-title>Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms</article-title><source>Psychopharmacology (Berl)</source><year>1995</year><volume>122</volume><fpage>301</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8748400</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF02246552</pub-id></element-citation></ref><ref id="R34"><label>34.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Vincler</surname><given-names>M</given-names></name><name name-style="western"><surname>Wittenauer</surname><given-names>S</given-names></name><name name-style="western"><surname>Parker</surname><given-names>R</given-names></name><name name-style="western"><surname>Ellison</surname><given-names>M</given-names></name><name name-style="western"><surname>Olivera</surname><given-names>BM</given-names></name><name name-style="western"><surname>McIntosh</surname><given-names>JM</given-names></name></person-group><article-title>Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>17880</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">17101979</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0608715103</pub-id><pub-id pub-id-type="pmcid">PMC1635975</pub-id></element-citation></ref><ref id="R35"><label>35.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Simons</surname><given-names>CT</given-names></name><name name-style="western"><surname>Cuellar</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moore</surname><given-names>JA</given-names></name><name name-style="western"><surname>Pinkerton</surname><given-names>KE</given-names></name><name name-style="western"><surname>Uyeminami</surname><given-names>D</given-names></name><name name-style="western"><surname>Carstens</surname><given-names>MI</given-names></name><etal/></person-group><article-title>Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke</article-title><source>Neurosci Lett</source><year>2005</year><volume>389</volume><fpage>71</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16095820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neulet.2005.07.025</pub-id></element-citation></ref><ref id="R36"><label>36.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>FJP</given-names></name><name name-style="western"><surname>Green</surname><given-names>PG</given-names></name><name name-style="western"><surname>Benowitz</surname><given-names>N</given-names></name><name name-style="western"><surname>Levine</surname><given-names>JD</given-names></name></person-group><article-title>Central terminals of nociceptors are targets for nicotine suppression of inflammation</article-title><source>Neuroscience</source><year>2004</year><volume>123</volume><fpage>777</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">14706790</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroscience.2003.10.027</pub-id></element-citation></ref><ref id="R37"><label>37.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M</given-names></name><name name-style="western"><surname>Ochani</surname><given-names>M</given-names></name><name name-style="western"><surname>Amella</surname><given-names>CA</given-names></name><name name-style="western"><surname>Tanovic</surname><given-names>M</given-names></name><name name-style="western"><surname>Susarla</surname><given-names>S</given-names></name><etal/></person-group><article-title>Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation</article-title><source>Nature</source><year>2003</year><volume>421</volume><fpage>384</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12508119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature01339</pub-id></element-citation></ref><ref id="R38"><label>38.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Berrendero</surname><given-names>F</given-names></name><name name-style="western"><surname>Mendiz&#225;bal</surname><given-names>V</given-names></name><name name-style="western"><surname>Robledo</surname><given-names>P</given-names></name><name name-style="western"><surname>Galeote</surname><given-names>L</given-names></name><name name-style="western"><surname>Bilkei-Gorzo</surname><given-names>A</given-names></name><name name-style="western"><surname>Zimmer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene</article-title><source>J Neurosci</source><year>2005</year><volume>25</volume><fpage>1103</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15689546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/JNEUROSCI.3008-04.2005</pub-id><pub-id pub-id-type="pmcid">PMC6725961</pub-id></element-citation></ref><ref id="R39"><label>39.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Pastore</surname><given-names>MN</given-names></name><name name-style="western"><surname>Kalia</surname><given-names>YN</given-names></name><name name-style="western"><surname>Horstmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>MS</given-names></name></person-group><article-title>Transdermal patches: History, development and pharmacology</article-title><source>Br J Pharmacol</source><year>2015</year><volume>172</volume><fpage>2179</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">25560046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bph.13059</pub-id><pub-id pub-id-type="pmcid">PMC4403087</pub-id></element-citation></ref><ref id="R40"><label>40.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Fant</surname><given-names>RV</given-names></name><name name-style="western"><surname>Henningfield</surname><given-names>JE</given-names></name><name name-style="western"><surname>Shiffman</surname><given-names>S</given-names></name><name name-style="western"><surname>Strahs</surname><given-names>KR</given-names></name><name name-style="western"><surname>Reitberg</surname><given-names>DP</given-names></name></person-group><article-title>A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches</article-title><source>Pharmacol Biochem Behav</source><year>2000</year><volume>67</volume><fpage>479</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">11164075</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0091-3057(00)00399-3</pub-id></element-citation></ref><ref id="R41"><label>41.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Benowitz</surname><given-names>NL</given-names></name><name name-style="western"><surname>Zevin</surname><given-names>S</given-names></name><name name-style="western"><surname>Jacob</surname><given-names>P</given-names></name></person-group><article-title>Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking</article-title><source>Br J Clin Pharmacol</source><year>1997</year><volume>43</volume><fpage>259</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">9088580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2125.1997.00566.x</pub-id><pub-id pub-id-type="pmcid">PMC2042749</pub-id></element-citation></ref><ref id="R42"><label>42.</label><element-citation publication-type="book" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Greenland</surname><given-names>S</given-names></name><name name-style="western"><surname>Satterfield</surname><given-names>MH</given-names></name><name name-style="western"><surname>Lanes</surname><given-names>SF</given-names></name></person-group><article-title>A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch</article-title><source>Database of Abstracts of Reviews of Effects (DARE): Quality-Assessed Reviews</source><publisher-name>Centre for Reviews and Dissemination</publisher-name><publisher-loc>UK</publisher-loc><year>1998</year><volume>18</volume><fpage>297</fpage><lpage>308</lpage><comment>doi: 10.2165/00002018-199818040-00005</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00002018-199818040-00005</pub-id><pub-id pub-id-type="pmid">9565740</pub-id></element-citation></ref><ref id="R43"><label>43.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Berner</surname><given-names>B</given-names></name><name name-style="western"><surname>John</surname><given-names>VA</given-names></name></person-group><article-title>Pharmacokinetic characterisation of transdermal delivery systems</article-title><source>Clin Pharmacokinet</source><year>1994</year><volume>26</volume><fpage>121</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">8162656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003088-199426020-00005</pub-id></element-citation></ref><ref id="R44"><label>44.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Jamner</surname><given-names>LD</given-names></name><name name-style="western"><surname>Girdler</surname><given-names>SS</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>D</given-names></name><name name-style="western"><surname>Jarvik</surname><given-names>ME</given-names></name></person-group><article-title>Pain inhibition, nicotine, and gender</article-title><source>Exp Clin Psychopharmacol Exp Clin Psychopharmacol</source><year>1998</year><volume>6</volume><fpage>96</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">9526150</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037//1064-1297.6.1.96</pub-id></element-citation></ref><ref id="R45"><label>45.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Mueser</surname><given-names>K</given-names></name><name name-style="western"><surname>Waller</surname><given-names>D</given-names></name><name name-style="western"><surname>Levander</surname><given-names>S</given-names></name><name name-style="western"><surname>Schalling</surname><given-names>D</given-names></name></person-group><article-title>Smoking and pain--a method of limits and sensory decision theory analysis</article-title><source>Scand J Psychol</source><year>1984</year><volume>25</volume><fpage>289</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">6528258</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1467-9450.1984.tb01021.x</pub-id></element-citation></ref><ref id="R46"><label>46.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Girdler</surname><given-names>SS</given-names></name><name name-style="western"><surname>Maixner</surname><given-names>W</given-names></name><name name-style="western"><surname>Naftel</surname><given-names>HA</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>PW</given-names></name><name name-style="western"><surname>Moretz</surname><given-names>RL</given-names></name><name name-style="western"><surname>Light</surname><given-names>KC</given-names></name></person-group><article-title>Cigarette smoking, stress-induced analgesia and pain perception in men and women</article-title><source>Pain</source><year>2005</year><volume>114</volume><fpage>372</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">15777863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pain.2004.12.035</pub-id></element-citation></ref><ref id="R47"><label>47.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Fillingim</surname><given-names>RB</given-names></name><name name-style="western"><surname>Ness</surname><given-names>TJ</given-names></name></person-group><article-title>Sex-related hormonal influences on pain and analgesic responses</article-title><source>Neurosci Biobehav Rev</source><year>2000</year><volume>24</volume><fpage>485</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">10817845</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0149-7634(00)00017-8</pub-id></element-citation></ref><ref id="R48"><label>48.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Millan</surname><given-names>MJ</given-names></name></person-group><article-title>Descending control of pain</article-title><source>Prog Neurobiol. Prog Neurobiol</source><year>2002</year><volume>66</volume><fpage>355</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">12034378</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0301-0082(02)00009-6</pub-id></element-citation></ref><ref id="R49"><label>49.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>LaRowe</surname><given-names>LR</given-names></name><name name-style="western"><surname>Ditre</surname><given-names>JW</given-names></name></person-group><article-title>Pain, nicotine, and tobacco smoking: Current state of the science</article-title><source>Pain</source><year>2020</year><volume>161</volume><fpage>1688</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">32701828</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/j.pain.0000000000001874</pub-id><pub-id pub-id-type="pmcid">PMC8924914</pub-id></element-citation></ref><ref id="R50"><label>50.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Lindson</surname><given-names>N</given-names></name><name name-style="western"><surname>Chepkin</surname><given-names>SC</given-names></name><name name-style="western"><surname>Ye</surname><given-names>W</given-names></name><name name-style="western"><surname>Fanshawe</surname><given-names>TR</given-names></name><name name-style="western"><surname>Bullen</surname><given-names>C</given-names></name><name name-style="western"><surname>Hartmann-Boyce</surname><given-names>J</given-names></name></person-group><article-title>Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation</article-title><source>Cochrane Database Syst Rev</source><year>2023</year><volume>6</volume><fpage>CD013308</fpage><pub-id pub-id-type="pmid">30997928</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD013308</pub-id><pub-id pub-id-type="pmcid">PMC6470854</pub-id></element-citation></ref><ref id="R51"><label>51.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Palazzo</surname><given-names>M</given-names></name><name name-style="western"><surname>Evans</surname><given-names>R</given-names></name></person-group><article-title>Logistic regression analysis of fixed patient factors for postoperative sickness: A model for risk assessment</article-title><source>Br J Anaesth</source><year>1993</year><volume>70</volume><fpage>135</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">8435254</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bja/70.2.135</pub-id></element-citation></ref><ref id="R52"><label>52.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Apfel</surname><given-names>CC</given-names></name><name name-style="western"><surname>Greim</surname><given-names>CA</given-names></name><name name-style="western"><surname>Haubitz</surname><given-names>I</given-names></name><name name-style="western"><surname>Goepfert</surname><given-names>C</given-names></name><name name-style="western"><surname>Usadel</surname><given-names>J</given-names></name><name name-style="western"><surname>Sefrin</surname><given-names>P</given-names></name><etal/></person-group><article-title>A risk score to predict the probability of postoperative vomiting in adults</article-title><source>Acta Anaesthesiol Scand</source><year>1998</year><volume>42</volume><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">9605363</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1399-6576.1998.tb05157.x</pub-id></element-citation></ref><ref id="R53"><label>53.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Stadler</surname><given-names>M</given-names></name><name name-style="western"><surname>Bardiau</surname><given-names>F</given-names></name><name name-style="western"><surname>Seidel</surname><given-names>L</given-names></name><name name-style="western"><surname>Albert</surname><given-names>A</given-names></name><name name-style="western"><surname>Boogaerts</surname><given-names>JG</given-names></name></person-group><article-title>Difference in risk factors for postoperative nausea and vomiting</article-title><source>Anesthesiology</source><year>2003</year><volume>98</volume><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">12502978</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000542-200301000-00011</pub-id></element-citation></ref><ref id="R54"><label>54.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Sweeney</surname><given-names>BP</given-names></name></person-group><article-title>Why does smoking protect against PONV?</article-title><source>Br J Anaesth</source><year>2002</year><volume>89</volume><fpage>810</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">12453921</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bja/aef269</pub-id></element-citation></ref><ref id="R55"><label>55.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Ionescu</surname><given-names>D</given-names></name><name name-style="western"><surname>Badescu</surname><given-names>C</given-names></name><name name-style="western"><surname>Acalovschi</surname><given-names>I</given-names></name></person-group><article-title>Nicotine patch for the prevention of postoperative nausea and vomiting: A prospective randomised trial</article-title><source>Clin Drug Investig</source><year>2007</year><volume>27</volume><fpage>559</fpage><lpage>64</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00044011-200727080-00004</pub-id><pub-id pub-id-type="pmid">17638396</pub-id></element-citation></ref><ref id="R56"><label>56.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Czarnetzki</surname><given-names>C</given-names></name><name name-style="western"><surname>Schiffer</surname><given-names>E</given-names></name><name name-style="western"><surname>Lysakowski</surname><given-names>C</given-names></name><name name-style="western"><surname>Haller</surname><given-names>G</given-names></name><name name-style="western"><surname>Bertrand</surname><given-names>D</given-names></name><name name-style="western"><surname>Tram&#232;r</surname><given-names>MR</given-names></name></person-group><article-title>Transcutaneous nicotine does not prevent postoperative nausea and vomiting: A randomized controlled trial</article-title><source>Br J Clin Pharmacol</source><year>2011</year><volume>71</volume><fpage>383</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">21284697</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2125.2010.03844.x</pub-id><pub-id pub-id-type="pmcid">PMC3045547</pub-id></element-citation></ref><ref id="R57"><label>57.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Guengerich</surname><given-names>FP</given-names></name></person-group><article-title>Cytochrome P450 2e1 and its roles in disease</article-title><source>Chem Biol Interact</source><year>2020</year><volume>322</volume><fpage>109056</fpage><comment>doi: 10.1016/j.cbi. 2020.109056</comment><pub-id pub-id-type="pmid">32198084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2020.109056</pub-id><pub-id pub-id-type="pmcid">PMC7217708</pub-id></element-citation></ref><ref id="R58"><label>58.</label><element-citation publication-type="book" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Gebhart</surname><given-names>G</given-names></name><name name-style="western"><surname>Sengupta</surname><given-names>J</given-names></name></person-group><article-title>On visceral nociceptor</article-title><source>Peripheral Neurons in Nociception: Phytopharmacological Aspects</source><publisher-loc>Paris</publisher-loc><publisher-name>Jonh Libbey Eurotext</publisher-name><year>1994</year><comment>Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.jvsmedicscorner.com/AnaesthPost_Anaesthesia,_Complications,_Consultant_Practice_files/Visceral%20pain%20review.pdf.1/25/2024">https://www.jvsmedicscorner.com/AnaesthPost_Anaesthesia,_Complications,_Consultant_Practice_files/Visceral%20pain%20review.pdf.1/25/2024</uri>. Last accessed on May 2024</comment></element-citation></ref><ref id="R59"><label>59.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Le Nov&#232;re</surname><given-names>N</given-names></name><name name-style="western"><surname>Corringer</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Changeux</surname><given-names>JP</given-names></name></person-group><article-title>The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences</article-title><source>J Neurobiol</source><year>2002</year><volume>53</volume><fpage>447</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">12436412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/neu.10153</pub-id></element-citation></ref><ref id="R60"><label>60.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Flood</surname><given-names>P</given-names></name><name name-style="western"><surname>Ramirez-Latorre</surname><given-names>J</given-names></name><name name-style="western"><surname>Role</surname><given-names>L</given-names></name></person-group><article-title>Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected</article-title><source>Anesthesiology</source><year>1997</year><volume>86</volume><fpage>859</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">9105230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000542-199704000-00016</pub-id></element-citation></ref><ref id="R61"><label>61.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Rada</surname><given-names>EM</given-names></name><name name-style="western"><surname>Tharakan</surname><given-names>EC</given-names></name><name name-style="western"><surname>Flood</surname><given-names>P</given-names></name></person-group><article-title>Volatile anesthetics reduce agonist affinity at nicotinic acetylcholine receptors in the brain</article-title><source>Anesth Analg</source><year>2003</year><volume>96</volume><fpage>108</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">12505934</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000539-200301000-00023</pub-id></element-citation></ref><ref id="R62"><label>62.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Flood</surname><given-names>P</given-names></name><name name-style="western"><surname>Coates</surname><given-names>KM</given-names></name></person-group><article-title>Sensitivity of the alpha7 nicotinic acetylcholine receptor to isoflurane may depend on receptor inactivation</article-title><source>Anesth Analg</source><year>2002</year><volume>95</volume><fpage>83</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12088948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000539-200207000-00015</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>